Wealthcare Advisory Partners’s AbbVie ABBV Stock Holding History

Wealthcare Advisory Partners’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$12.7M	Sell	50,422 -2,254	-4%	-$485K	0.24%	85
2026 Q1	$11.5M	Sell	52,676 -16,701	-24%	-$3.7M	0.22%	93
2025 Q4	$15.9M	Buy	69,377 +23,065	+50%	+$5.25M	0.31%	68
2025 Q3	$10.7M	Buy	46,312 +307	+0.7%	+$62.5K	0.22%	96
2025 Q2	$8.54M	Buy	46,005 +2,103	+5%	+$391K	0.19%	106
2025 Q1	$9.2M	Buy	43,902 +664	+2%	+$129K	0.25%	80
2024 Q4	$7.68M	Sell	43,238 -53	-0.1%	-$9.74K	0.21%	92
2024 Q3	$8.55M	Sell	43,291 -510	-1%	-$95.2K	0.24%	83
2024 Q2	$7.51M	Buy	43,801 +964	+2%	+$160K	0.23%	77
2024 Q1	$7.8M	Buy	42,837 +8,184	+24%	+$1.41M	0.26%	74
2023 Q4	$5.37M	Buy	34,653 +1,314	+4%	+$192K	0.21%	82
2023 Q3	$4.97M	Sell	33,339 -322	-1%	-$47.3K	0.23%	81
2023 Q2	$4.54M	Sell	33,661 -6,105	-15%	-$895K	0.2%	91
2023 Q1	$6.34M	Buy	39,766 +581	+1%	+$88.8K	0.27%	69
2022 Q4	$6.33M	Buy	39,185 +6,172	+19%	+$946K	0.3%	63
2022 Q3	$4.43M	Buy	33,013 +1,177	+4%	+$169K	0.25%	80
2022 Q2	$4.88M	Sell	31,836 -1,179	-4%	-$180K	0.3%	62
2022 Q1	$5.35M	Sell	33,015 -3,401	-9%	-$494K	0.33%	48
2021 Q4	$4.93M	Sell	36,416 -3,755	-9%	-$444K	0.29%	51
2021 Q3	$4.33M	Buy	40,171 +1,028	+3%	+$117K	0.28%	53
2021 Q2	$4.41M	Sell	39,143 -1,009	-3%	-$114K	0.3%	51
2021 Q1	$4.34M	Buy	40,152 +11,779	+42%	+$1.26M	0.31%	41
2020 Q4	$3.04M	Buy	28,373 +1,014	+4%	+$97.4K	0.27%	50
2020 Q3	$2.4M	Buy	27,359 +1,833	+7%	+$173K	0.26%	47
2020 Q2	$2.51M	Buy	25,526 +4,000	+19%	+$352K	0.31%	42
2020 Q1	$1.64M	Sell	21,526 -642	-3%	-$54.7K	0.24%	54
2019 Q4	$1.96M	Buy	22,168 +13,231	+148%	+$1.1M	0.25%	52
2019 Q3	$677K	Sell	8,937 -1,002	-10%	-$68.7K	0.1%	120
2019 Q2	$723K	Sell	9,939 -504	-5%	-$39.6K	0.11%	104
2019 Q1	$842K	Sell	10,443 -7,723	-43%	-$632K	0.14%	89
2018 Q4	$1.68M	Buy	18,166 +498	+3%	+$43.8K	0.33%	47
2018 Q3	$1.67M	Buy	17,668 +15	+0.1%	+$1.42K	0.31%	47
2018 Q2	$1.64M	Buy	17,653 +521	+3%	+$50.9K	0.32%	48
2018 Q1	$1.62M	Sell	17,132 -2,346	-12%	-$258K	0.37%	42
2017 Q4	$1.88M	Buy	19,478 +403	+2%	+$38K	0.48%	28
2017 Q3	$1.7M	Buy	19,075 +19,074	+1,907,400%	+$1.45M	0.5%	27
2017 Q2	$0	Hold	1	–	–	﹤0.01%	100
2017 Q1	$0	Hold	1	–	–	﹤0.01%	99
2016 Q4	$0	Hold	1	–	–	﹤0.01%	98
2016 Q3	$0	Hold	1	–	–	﹤0.01%	77
2016 Q2	$0	Buy	+1	New	+$61	﹤0.01%	103

Other funds holding ABBV

LMFP

Larry Mathis Financial Planning Phoenix, Arizona $124B AUM

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

ATO

Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

HCM

Hamlin Capital Management New York $4.45B AUM 22.95% 1-Year Est. Return

AAMU

AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return

FWCM

Ferguson Wellman Capital Management Portland, Oregon $8.19B AUM 30.56% 1-Year Est. Return

Wealthcare Advisory Partners's ABBV Position: Q2 2026 in Review

Wealthcare Advisory Partners reduced its AbbVie (ABBV) stake by 4.3% in Q2 2026, selling an estimated $485K and leaving 50,422 shares worth $12.7M. The position accounts for 0.24% of the portfolio, ranked #85.

Wealthcare Advisory Partners first reported a position in ABBV in Q2 2016 and has held it in 41 quarters since. The position peaked at $15.9M in Q4 2025. 1,326 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Wealthcare Advisory Partners held 50,422 shares of AbbVie worth $12.7M as of Q2 2026.
Wealthcare Advisory Partners sold 2,254 AbbVie shares in Q2 2026, an estimated $485K.
AbbVie made up 0.24% of Wealthcare Advisory Partners's portfolio in Q2 2026, its #85 holding.
Wealthcare Advisory Partners first reported a position in AbbVie in Q2 2016 and has held it in 41 quarters since.
Wealthcare Advisory Partners's AbbVie position peaked at $15.9M in Q4 2025.
1,326 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Wealthcare Advisory Partners's 13F filing for Q2 2026, filed 9 Jul 2026.